에 대한 최신 뉴스 Moleculin Biotech (NASDAQ:MBRX) 주식

Moleculin Biotech

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.

Moleculin Biotech Inc

Michael Jordan's legendary Chicago estate has taken on a new life under its latest owner. After <a href="https://www.benzinga.com/real-estate/24/12/42638801/before-his-180-on-climate-change-elon-musk-advocated-for-action-cautioning-that-oceanfront-real-estate-values-would-plummet-2">sitting on the market</a> for over a decade, the sprawling Highland Park mansion finally sold for $9.5 million in December. But instead of keeping it as a private home, the new buyer, John Cooper, is already shaking things up—turning it into a luxury rental at a jaw-dropping $230,000 per month and selling off shares of the property in a unique timeshare model.
<h2 class="wp-block-heading">A Discounted Sale After 12 Years on the Market</h2>
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Michael Jordan&#39;s mansion sitting seven acres with nine beds and 19 baths &#x1f92f; <a href="https://t.co/ZjQV0wDOdq">pic.twitter.com/ZjQV0wDOdq</a>
&mdash; The Instigator (@Am_Blujay) <a href="https://twitter.com/Am_Blujay/status/1787188879541317787?ref_src=twsrc%5Etfw">May 5, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Don't Miss:
<ul>
<li>This Jeff Bezos-backed startup will allow you to <a href="https://arrivedhomes.go2cloud.org/aff_c?offer_id=15&amp;aff_id=1006&amp;aff_sub=yahoo&amp;aff_sub2=byerscta100">become a landlord in just 10 minutes, with minimum investments as low as $100</a>.</li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl-y2"> you can become an investor for $0.80 per share today.</a></li>
</ul>
Jordan originally listed the 56,000-square-foot estate in 2012 for $29 million, but it <a href="https://www.benzinga.com/markets/24/12/42678673/michael-jordan-sells-his-massive-luxury-mansion-for-9-5-million-but-it-took-12-years-to-find-a-buyer-and-he-spent-50-million-building-it">struggled to attract buyers</a>, despite multiple price cuts and the home's deep ties to the basketball legend. The mansion, known as Legend Point, boasts nine bedrooms, 19 bathrooms, a full-size basketball court, a cigar lounge, and even doors from the original Playboy Mansion. After years of markdowns, Cooper, a real estate investor from Nebraska, purchased the property for $9.5 million—a significant drop from its original asking price.
<h2 class="wp-block-heading">Turning Legend Point Into A Business</h2>
Rather than using the mansion as his primary residence, Cooper quickly set plans in motion to monetize the iconic home. Per Realtor.com, just weeks after closing the deal, he announced that portions of the property would be sold as luxury timeshares under the name &#8220;Champions Point.&#8221; Co-owners can buy a share for at least $1 million, granting them access to the estate for a designated week each year. Owners can invite up to 24 guests and even host high-end events for an extra fee.
Trending: Many don&#8217;t know there are tax benefits when buying a unit as an investment —<a href="https://www.benzinga.com/money/casa-shares-y2"> Here&#8217;s how to invest in real estate by mirroring BlackRock's big move</a>
Now, in addition to selling shares, Cooper has listed the entire estate for rent, offering anyone with deep enough pockets the chance to live in Jordan's former home for $230,000 a month. The listing describes it as a &#8220;once-in-a-lifetime opportunity&#8221; for those who &#8220;live and breathe sports.&#8221;
<h2 class="wp-block-heading">What Renters and Co-Owners Get</h2>
The mansion's amenities are as grand as its history. Renters and co-owners gain access to a regulation-size basketball court, an infinity pool with an island, a tennis court, a putting green, a state-of-the-art home theater, a wine cellar, a commercial-grade fitness center, and a cigar room with a custom humidor. High-end add-ons, including private chefs, on-site entertainment, and luxury transportation, are also available for an extra cost.
Cooper, a longtime Bulls fan who has lived in Chicago for the past decade, says he wants to preserve the property's legacy while also making it more accessible to sports enthusiasts, celebrities, and businesses looking for a one-of-a-kind luxury experience.
Read Next:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-y2">Last Chance to get 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
<li><a href="https://www.benzinga.com/go/arrived-private-credit-yf">Arrived Home's Private Credit Fund&#8217;s has historically paid an annualized dividend yield of 8.1%&#x2A;</a>, which provides access to a pool of short-term loans backed by residential real estate with just a $100 minimum.<a href="https://www.benzinga.com/go/arrived-private-credit-yf"> </a></li>
</ul>

Markets

Michael Jordan's Former $9.5 Million Chicago Megamansion Is Now A $230,000/Month Rental As Its New Owner Sells Off Pieces Of The Property

Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) CEO Tim Cook has reportedly pledged a significant investment in the United States and a shift in manufacturing from Mexico to the U.S. President Donald Trump made this announcement during a meeting with governors.
What Happened: After <a href="https://www.benzinga.com/markets/equities/25/02/43876173/apple-ceo-tim-cook-reportedly-meets-trump-as-tariff-impact-looms-on-iphone-sales-and-companys-china-strategy">meeting Cook at the White House </a>this week, Trump revealed that the Apple CEO had assured him of moving iPhone maker&#8217;s manufacturing from Mexico to the U.S.
 &#8220;He&#8217;s&nbsp;investing hundreds of billions of&nbsp;dollars&#8230; That&#8217;s&nbsp;what he told me. Now&nbsp;he has to do it,&#8221; Trump said.
Trump also mentioned that Cook had halted two plants in Mexico and would now be producing Apple products in the U.S. However, Cook has not yet publicly announced any such investment.
"They don't want to be in the tariffs," Trump said.
See Also:&nbsp;<a href="https://in.benzinga.com/markets/equities/25/02/43873396/apple-stock-has-run-up-over-10-in-a-month-jim-cramer-says-iphone-maker-is-ramping-and-the-credit-goes-to-chinese-subsidies" target="_blank" rel="noreferrer noopener">Apple Stock Has Run Up Over 10% In A Month, Jim Cramer Says iPhone Maker Is ‘Ramping' And The Credit Goes To Chinese Subsidies</a>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="TRUMP DOGE EFFECT: President Trump FULL REMARKS on Spending, Ukraine War, Taxes, Migrants" width="500" height="281" src="https://www.youtube.com/embed/b92O_a3MkpA?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
It's unclear which manufacturing facilities Trump was referring to. Foxconn Technology Group, the maker of Apple's iPhones, already has a strong presence in Mexico and plans to expand further.
Apple did not immediately respond to <a href="http://pro.benzinga.com">Benzinga&#8217;s</a> request for comment. 
Why It Matters: The news of Apple&#8217;s potential shift in manufacturing and significant U.S. investment comes at a crucial time for the tech giant. Like other tech giants, Apple is grappling with <a href="https://www.benzinga.com/trading-ideas/25/02/43827658/exclusive-apple-nvidia-tesla-or-boeing-which-company-faces-the-biggest-risk-from-trumps-china-tariffs-35-say-this-stock">rising U.S.-China trade tensions.</a> Trump&#8217;s 10% tariff on Chinese-made goods poses a significant challenge, as China remains Apple's primary manufacturing hub, and the U.S., is its largest market.
According to an analyst at Bank of America, the <a href="https://www.benzinga.com/markets/equities/25/02/43839627/apple-may-hike-iphone-prices-by-9-due-to-trumps-tariffs-says-bank-of-america">iPhone maker will need to hike prices</a> on iPhones, iPads, and other products by approximately 9% to counter the effect of tariffs. assuming a minimum 10% tariff applies to all of them. The analyst also expects a potential hit on the sales volume.
On Wednesday, Apple unveiled the iPhone 16e, <a href="https://www.benzinga.com/tech/25/02/43820197/apple-unveils-iphone-16e-with-a18-chip-ai-features-599-price-tag">a budget-friendly successor</a> to the third-generation iPhone SE. Priced at $599, the device is designed to run artificial intelligence efficiently.
Check out more of Benzinga&#8217;s Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://in.benzinga.com/markets/25/02/43840286/apples-iphone-16e-to-drive-revenue-growth-for-tim-cooks-company-says-top-analyst" target="_blank" rel="noreferrer noopener">Apple's iPhone 16e To Drive Revenue Growth For Tim Cook's Company, Says Top Analyst</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Government

News

Tech

AAPL

Tim Cook Reportedly Tells Trump Apple Will Invest 'Hundreds Of Billions' In US: 'They Don't Want To Be In The Tariffs'

Elon Musk&#8217;s unsolicited $97 billion bid for OpenAI&#8216;s assets has created a valuation challenge for the artificial intelligence leader, potentially complicating its planned transition to a for-profit structure.
Legal experts suggest the offer, <a href="https://www.benzinga.com/25/02/43755069/openai-board-rejects-elon-musks-97-billion-acquisition-proposal-days-after-sam-altman-calls-it-a-move-to-slow-down-a-competitor#:~:text=OpenAI%20Board%20Rejects%20Elon%20Musk's,Slow%20Down'%20A%20Competitor%20%2D%20Benzinga">though swiftly rejected</a>, could force regulators to scrutinize OpenAI&#8217;s corporate restructuring more closely. The bid &#8220;will be more difficult to justify valuing the nonprofit&#8217;s assets at less than $97 billion if there is a concrete offer for that sum,&#8221; <a href="https://www.economist.com/business/2025/02/11/elon-musks-97bn-offer-is-a-headache-for-sam-altmans-openai">according to a report by The Economist</a>.
Don't Miss:
<ul>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
</ul>
Musk, OpenAI&#8217;s co-founder and now rival, submitted the bid through a consortium on Feb. 11, targeting the non-profit entity that controls the company. The move escalates his feud with CEO Sam Altman over the company&#8217;s shift toward a more traditional corporate structure.
&#8220;OpenAI is not for sale,&#8221; company spokesman Chris Lehane told The Economist.
The timing appears strategic, as OpenAI reportedly seeks to <a href="https://www.benzinga.com/media/25/01/43374528/softbank-may-lead-openais-40-billion-funding-round-at-a-300-billion-valuation-despite-deepseek-disruption-report">raise approximately $40 billion from investors, including SoftBank</a>. Musk&#8217;s bid could potentially disrupt the fundraising efforts by raising questions about proper valuation during the company&#8217;s restructuring.
Trending: <a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.
Jill Horwitz, law professor at the University of California, Los Angeles, said that the nonprofit board&#8217;s fiduciary duty is to act according to OpenAI&#8217;s legal purpose—building safe artificial intelligence that &#8220;benefits all of humanity.&#8221; The mission-focused obligation may provide flexibility in responding to acquisition offers.
Musk&#8217;s legal team has urged attorneys general in California and Delaware, where OpenAI operates, to ensure the nonprofit surrenders control at fair market value during any restructuring.&nbsp;
While company insiders doubt state officials will acquiesce to Musk, Horwitz noted they have &#8220;clear law to apply&#8221; regarding proper valuation.
See Also: <a href="https://www.benzinga.com/money/elon-musk-told-the-u-n-if-they-could-show-a-plan-for-ending-world-hunger-hed-donate-6-billion-i-will-sell-tesla-stock-right-now-and-do-it">Elon Musk Told The U.N. If They Could Show A Plan For Ending World Hunger He'd Donate $6 Billion – ‘I Will Sell Tesla Stock Right Now And Do It'</a>
The bid follows recent tensions over the &#8220;Stargate Project,&#8221; a $100 billion data center investment fund announced by Altman and President Donald Trump on Jan. 21. Musk publicly questioned whether the project&#8217;s backers had sufficient funding, allegations they denied.
Altman responded to Musk&#8217;s bid with a facetious counteroffer on X—$9.7 billion to &#8220;buy Twitter,&#8221; as Musk&#8217;s social network was previously known. &#8220;I think he&#8217;s just trying to slow us down,&#8221; <a href="https://www.bloomberg.com/news/videos/2025-02-11/altman-says-musk-probably-just-trying-to-slow-us-down-video">Altman told Bloomberg</a>. &#8220;I feel for the guy. I don&#8217;t think he&#8217;s a happy person.&#8221;
The offer represents another front in Musk&#8217;s competitive strategy against his largest AI rival. He launched xAI in 2023, positioning it as a direct competitor to OpenAI.
Read Next:
<ul>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
</ul>

Experts Say Musk's $97 Billion Offer Could Force OpenAI To Reassess Its Value

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

SXTP

ALPS ETF Trusthen & Steers Global Realty Majors ETF

SXTPW

A top Democrat warned last week that the White House's  government efficiency team could disrupt tax refund processing as representatives <a href="https://www.benzinga.com/25/02/43754316/irs-gears-up-to-lay-off-thousands-of-workers-potentially-impacting-tax-season-no-analysis-to-the-impact-it-will-have-on-operations">began examining Internal Revenue Service operations during peak filing season</a>.
Gavin Kliger, a member of the Department of Government Efficiency that is being led by Elon Musk, visited IRS headquarters in Washington on Feb. 13, requesting detailed information about agency operations and staffing, <a href="https://www.cnn.com/2025/02/13/politics/doge-visits-the-irs-putting-staffers-on-edge/index.html">according to CNN</a>.
&#8220;My office is hearing that DOGE is now at the IRS. That means Musk&#8217;s henchmen are in a position to dig through a trove of data about every taxpayer in America. And if your refund is delayed, they could very well be the reason,&#8221; Sen. Ron Wyden (D-OR) <a href="https://x.com/RonWyden/status/1890114168583565673">wrote on X</a>.
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/are-you-rich-2">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
<li>How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.</li>
</ul>
The visit marks the efficiency department&#8217;s first direct engagement with the tax agency, which employs approximately 100,000 workers. According to CNN, Kliger requested information about each business unit&#8217;s responsibilities and risk factors.
An email shared with CNN that was sent to IRS employees during the visit instructed staff to route queries about &#8220;high-profile visitors&#8221; through proper channels, noting the matter had been &#8220;elevated to Treasury&#8221; for further instruction.
President Donald Trump authorized the IRS review earlier in the day on Feb. 13, telling reporters, &#8220;the Internal Revenue Service will be looked at like everybody else.&#8221; When asked if he expected the agency to be closed, Trump responded: &#8220;No, I don&#8217;t expect it. But I think the Internal Revenue Service will be looked at like everybody else.&#8221;
Trending: Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"> The percentage may shock you</a>.
The audit follows an <a href="https://x.com/elonmusk/status/1886847092888310231?lang=en">informal poll on X</a> where Musk asked followers if they favored reviewing the IRS. The poll showed 91.2% support among respondents. The billionaire issued a poll earlier in December <a href="https://www.benzinga.com/personal-finance/24/12/42380263/elon-musk-asks-if-irs-funding-should-be-deleted-more-than-60-of-respondents-said-yes#:~:text=Billionaire%20entrepreneur%20Elon%20Musk%20sparked,delete%22%20the%20agency's%20funding%20entirely.">calling for the IRS to be "deleted,"</a> which saw 60.4% of respondents agree with the proposition.
House Ways and Means Committee Chairman Jason Smith (R-MO) embraced the scrutiny <a href="https://waysandmeans.house.gov/2025/02/13/chairman-smith-business-as-usual-at-the-irs-is-unacceptable/">in a letter</a> to Acting IRS Commissioner Douglas O&#8217;Donnell. &#8220;Business as usual at the IRS is unacceptable,&#8221; Smith wrote. &#8220;Our government has not been working effectively for the American people, and it needs to change.&#8221;
See Also: <a href="https://www.benzinga.com/money/elon-musk-told-the-u-n-if-they-could-show-a-plan-for-ending-world-hunger-hed-donate-6-billion-i-will-sell-tesla-stock-right-now-and-do-it">Elon Musk Told The U.N. If They Could Show A Plan For Ending World Hunger He'd Donate $6 Billion – ‘I Will Sell Tesla Stock Right Now And Do It'</a>
The IRS already faces hiring restrictions under Trump&#8217;s Jan. 20 executive order freezing federal employment. While the broader hiring freeze expires after 90 days, <a href="https://www.whitehouse.gov/presidential-actions/2025/01/hiring-freeze/">the order</a> says that IRS restrictions will remain until the treasury secretary determines &#8220;it is in the national interest to lift the freeze.&#8221;
No operational changes or layoffs have been announced. <a href="https://www.wsj.com/politics/policy/doge-internal-revenue-service-9697cb99#:~:text=Kliger%20doesn't%20have%20access,obtain%20or%20view%20taxpayer%20information.">The Wall Street Journal reported</a> that a source said Kliger did not access IRS computer systems or taxpayer information during his visit.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/mark-cubans-advice-for-lotto-winners">Many are surprised by Mark Cuban's advice for lotto winners: Cash or annuity?</a></li>
<li><a href="https://www.benzinga.com/money/millionaires-never-earned-six-figures-according-to-dave-ramsey">69% of Millionaires Never Earned A Six-Figure Salary – Here Are 2 Things They Do To Get Their First $1 Million, According To Dave Ramsey</a></li>
</ul>

Personal Finance

'If Your Refund Is Delayed, They Could Be The Reason,' Senator Sounds Alarm On Musk's IRS Audit

FirstCash Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCFS#NASDAQ">FCFS</a>) has outperformed the market over the past 20 years by 3.64% on an annualized basis producing an average annual return of 11.97%. Currently, FirstCash Hldgs has a market capitalization of $5.13 billion. 
Buying $1000 In FCFS: If an investor had bought $1000 of FCFS stock 20 years ago, it would be worth $9,482.00 today based on a price of $114.59 for FCFS at the time of writing.
<h3>FirstCash Hldgs's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740181511_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

FCFS

Here's How Much You Would Have Made Owning FirstCash Hldgs Stock In The Last 20 Years

Burlington Stores (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BURL#NYSE">BURL</a>) has outperformed the market over the past 10 years by 4.78% on an annualized basis producing an average annual return of 15.78%. Currently, Burlington Stores has a market capitalization of $14.84 billion. 
Buying $1000 In BURL: If an investor had bought $1000 of BURL stock 10 years ago, it would be worth $4,359.22 today based on a price of $233.80 for BURL at the time of writing.
<h3>Burlington Stores's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740180608_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BURL

Here's How Much You Would Have Made Owning Burlington Stores Stock In The Last 10 Years

East West Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWBC#NASDAQ">EWBC</a>) has outperformed the market over the past 5 years by 4.19% on an annualized basis producing an average annual return of 18.12%. Currently, East West Bancorp has a market capitalization of $13.00 billion. 
Buying $1000 In EWBC: If an investor had bought $1000 of EWBC stock 5 years ago, it would be worth $2,161.37 today based on a price of $93.89 for EWBC at the time of writing.
<h3>East West Bancorp's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740179709_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EWBC

If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today

Costco Wholesale (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>) has outperformed the market over the past 15 years by 8.84% on an annualized basis producing an average annual return of 20.69%. Currently, Costco Wholesale has a market capitalization of $459.45 billion. 
Buying $100 In COST: If an investor had bought $100 of COST stock 15 years ago, it would be worth $1,697.61 today based on a price of $1035.03 for COST at the time of writing.
<h3>Costco Wholesale's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740178810_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

COST

$100 Invested In Costco Wholesale 15 Years Ago Would Be Worth This Much Today

Taiwan Semiconductor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) has outperformed the market over the past 20 years by 8.72% on an annualized basis producing an average annual return of 17.04%. Currently, Taiwan Semiconductor has a market capitalization of $1.03 trillion. 
Buying $1000 In TSM: If an investor had bought $1000 of TSM stock 20 years ago, it would be worth $23,508.40 today based on a price of $198.00 for TSM at the time of writing.
<h3>Taiwan Semiconductor's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740177909_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Taiwan Semiconductor 20 Years Ago Would Be Worth This Much Today

<a href="https://www.bloomberg.com/news/articles/2025-02-21/blackstone-nears-1-7-billion-deal-for-summit-backed-vaxcare" title="https://www.bloomberg.com/news/articles/2025-02-21/blackstone-nears-1-7-billion-deal-for-summit-backed-vaxcare">https://www.bloomberg.com/news/articles/2025-02-21/blackstone-nears-1-7-billion-deal-for-summit-backed-vaxcare</a>

'Blackstone Nears $1.7B Deal for Summit-Backed VaxCare' - Bloomberg News

Coca-Cola Consolidated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COKE#NASDAQ">COKE</a>) has outperformed the market over the past 15 years by 11.93% on an annualized basis producing an average annual return of 23.78%. Currently, Coca-Cola Consolidated has a market capitalization of $12.11 billion. 
Buying $100 In COKE: If an investor had bought $100 of COKE stock 15 years ago, it would be worth $2,484.92 today based on a price of $1382.86 for COKE at the time of writing.
<h3>Coca-Cola Consolidated's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740177024_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

COKE

Here's How Much You Would Have Made Owning Coca-Cola Consolidated Stock In The Last 15 Years

Cryptocurrency markets are trading lower on Friday after a $1.4 billion hack on Bybit dragged down the market.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>$95,385.38</td>
<td>-3.1%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>$2,634.96</td>
<td>-4.3%</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>$168.78</td>
<td>-3.5%</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>$2.52</td>
<td>-6.9%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.2400</td>
<td>-5.6%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00001494</td>
<td>-4%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul>
<li>IntoTheBlock data shows large transaction volume increasing by 12.3% and daily active addresses growing by 4%. Transactions greater than $100,000 are up from 9,587 to 9,988 in a single day. Exchanges netflows are up by 105.3%.</li>
<li>Coinglass data reports 188,950 traders were liquidated in the past 24 hours for $551.47 million.</li>
</ul>
Notable Developments:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43886224/bybit-founder-confirms-1-4-billion-ethereum-hack-blames-masked-transaction">Bybit Founder Confirms $1.4 Billion Ethereum Hack, Blames &#8216;Masked&#8217; Transaction</a></li>
<li><a href="https://in.benzinga.com/markets/cryptocurrency/25/02/43883117/coinbase-ceo-brian-armstrong-says-sec-has-agreed-to-end-bogus-enforcement-case-without-penalties">Coinbase CEO Brian Armstrong Says SEC Has Agreed To End &#8216;Bogus&#8217; Enforcement Case Without Penalties</a></li>
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/02/43887659/coinbase-shares-rise-as-sec-moves-to-drop-lawsuit-whats-going-on">Coinbase Shares Rise As SEC Moves To Drop Lawsuit: What&#8217;s Going On?</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43878748/michael-saylor-bitcoin-is-economic-armor-calls-on-us-to-accumulate-btc">Michael Saylor: &#8216;Bitcoin Is Economic Armor&#8217;, Calls On US To Accumulate BTC</a></li>
<li><a href="https://www.benzinga.com/25/02/43876426/new-fbi-director-kash-patel-holds-over-100000-in-bitcoin-etfs-has-significant-exposure-to-btc-miner-core-scientific">New FBI Director Kash Patel Holds Over $100,000 In Bitcoin ETFs, Has Significant Exposure To BTC Miner Core Scientific</a></li>
</ul>
Top Gainers:
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Story (CRYPTO: IP)</td>
<td>&nbsp;$4.51</td>
<td>+17.8%</td>
</tr>
<tr>
<td>Jito (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">JTO</a>)</td>
<td>&nbsp;$3.04</td>
<td>+11.7%</td>
</tr>
<tr>
<td>Bitget Token (CRYPTO: BGB)</td>
<td>&nbsp;$4.67</td>
<td>+3%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: More Crypto Online <a href="https://x.com/Morecryptoonl/status/1892996131896074459">noted</a> that Bitcoin has confirmed a local top, aligning with broader market trends. The price failed to sustain above the Feb. 14 high. For a bullish continuation, it should hold above $94,645 in this potential wave 2. The key invalidation level is $93,450.
Crypto trader CJ explained Bitcoin has tagged last week&#8217;s high and low. It provided clean trades on both sides of the range. The trader awaits to see if mid-range demand holds. Ideally, BTC ranges through the weekend.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> Previous week high and low tagged. Both sides of the range produced a very clean trade. Let&#39;s see if the mid-range demand holds or not. Ideally just range for the weekend. Notable strength on a couple alts here e.g. ENA &#x1f37f; <a href="https://t.co/d8TtHjecRz">pic.twitter.com/d8TtHjecRz</a>
&mdash; CJ (@CJ900X) <a href="https://twitter.com/CJ900X/status/1893001814422802655?ref_src=twsrc%5Etfw">February 21, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Crypto trader Jelle reaffirmed his expectations and <a href="https://x.com/CryptoJelleNL/status/1893015465988944344">predicts</a> that market looks good for a strong end to the month.
Read Next:&nbsp;
<ul>
<li><a href="https://in.benzinga.com/markets/cryptocurrency/25/02/43889897/bitcoin-strategic-reserve-with-1-million-btc-could-offset-21-trillion-national-debt">Bitcoin Reserve With 1 Million BTC Could Offset $21 Trillion National Debt By 2049, Expert Says</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BGB

$BTC

$DOGE

$ETH

$JTO

$SHIB

$SOL

$XRP

Bitcoin, Ethereum, XRP, Dogecoin See Friday Blues After Massive $1.4 Billion Bybit Hack

Hooters of America is huddling up with its creditors to cook up a <a href="https://www.benzinga.com/topic/bankruptcy">bankruptcy restructuring plan</a>. 
The famous BBQ wing chain has enlisted legal heavyweights at Ropes &amp; Gray to prep the filing, according to <a href="https://www.bloomberg.com/news/articles/2025-02-21/hooters-in-talks-to-prepare-a-bankruptcy-filing-in-coming-months?srnd=homepage-americas&amp;sref=TBDibEcD">Bloomberg</a>. The court showdown could kick off within the next two months.
Known for its crop-top uniforms and winking owl mascot, Hooters is trying to get its financial house in order with help from turnaround pros at boutique firm Accordion Partners. 
Meanwhile, some of its lenders have brought in Houlihan Lokey to also advise the process.
<h2 class="wp-block-heading">What Else Is On The Bankruptcy Block?</h2>
Hooters isn&#8217;t the only sit-down dining spot feeling the heat of Chapter 11. 
Mediterranean fast-casual chain Rōti, for example, recently sold out of bankruptcy. According to <a href="https://www.chicagobusiness.com/restaurants/roti-sold-out-bankruptcy-edible-arrangements-founder">Crain&#8217;s Chicago</a>, a private-equity firm led by the founder of Edible Arrangements agreed to take it over. 
Rōti will retain 17 of its 19 locations once the deal is complete.
The culprit behind these filings? Fewer customers waltzing through doors thanks to <a href="https://www.emarketer.com/content/dining-inflation-remains-higher-than-food-home--forcing-restaurants-compete-on-value">inflation</a>. Plus, supply chain headaches, and soaring interest rates are pushing menu prices skyward. As a result, more folks are opting to cook at home. 
More than a dozen major restaurant groups or franchisees waved the white flag and filed for bankruptcy last year, including <a href="https://www.benzinga.com/news/24/05/38992673/the-craziest-parts-of-the-red-lobster-bankruptcy-story-revealed">Red Lobster</a> and <a href="https://www.benzinga.com/m-a/24/11/41700829/deal-dispatch-tgi-fridays-goes-bankrupt-bhp-backtracks-comments-and-more-m-a-news">TGI Fridays</a>. 
<h2 class="wp-block-heading">New On The Block</h2>
<ul>
<li>Family Dollar, a discount retailer owned by Dollar Tree (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTR#NASDAQ">DLTR</a>), is for sale. Reuters reports that several buyout firms — Apollo Global Management, Sycamore Partners,and Brigade Capital Management — are interested.</li>
</ul>
<ul>
<li>HBM Healthcare Investments is shopping Baar, Switzerland-based Swixx Biopharma to potential buyers. Bloomberg put the valuation at about 1.5 billion Swiss francs ($1.7 billion). Jefferies Financial Group Inc. and Centerview Partners are handling <a href="https://www.bloomberg.com/news/articles/2025-02-20/hbm-is-said-to-consider-1-7-billion-sale-of-swixx-biopharma?sref=TBDibEcD">the sale</a>.</li>
</ul>
<h2 class="wp-block-heading">Updates From The Block</h2>
<ul>
<li>Italian media outlet Daily Il Sole 24 <a href="https://www.ilsole24ore.com/art/prada-stretta-versace-esclusiva-quattro-settimane-AGHcQc0C">reports</a> that Prada Group is actively trying to buy Versace. Investment bank Citi is reportedly advising Prada on a potential acquisition. Versace has been under the ownership of Capri Holdings since 2018. Since mid-December, speculation has been mounting that Capri is gearing up to sell Versace, along with another brand in its portfolio—Jimmy Choo. Barclays is advising Capri Holdings to circulate the dossier among potential buyers. This week, Bloomberg <a href="https://www.bloomberg.com/news/articles/2025-02-19/prada-works-with-advisers-to-evaluate-versace-for-possible-bid?srnd=phx-deals&amp;embedded-checkout=true&amp;sref=TBDibEcD">reported</a> that Prada has gained access to Versace&#8217;s latest financial and sales figures.</li>
</ul>
<ul>
<li>Carlyle Group, Thoma Bravo, and TA Associates have advanced to the final bidding round for French software firm SmartTrade Technologies, <a href="https://www.bloomberg.com/news/articles/2025-02-20/carlyle-thoma-bravo-shortlisted-in-bidding-for-smarttrade?sref=TBDibEcD">Bloomberg</a> reports. Current offers value the company at $577 million. Hg, SmartTrade's owner, aims to select a buyer by late March.</li>
</ul>
<ul>
<li>Private equity firms are also <a href="https://www.bloomberg.com/news/articles/2025-02-21/kkr-s-goodpack-sale-is-said-to-attract-apollo-i-squared-stonepeak?sref=TBDibEcD">lining up</a> for Goodpack, a Singapore-based logistics service provider. The price tag is expected to be about $1.5 billion. KKR &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>) is on the sell side, while Apollo Global Management Inc., I Squared Capital and Stonepeak Partners are among the bidders.</li>
</ul>
<h2 class="wp-block-heading">Off The Block</h2>
<ul>
<li>Alani Nu, a female-focused energy drink brand, agreed to a deal with Celsius (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NASDAQ">CELH</a>) for $1.8 billion. This is just the latest in a string of <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/06/27846252/could-pepsico-buyout-celsius-holdings-or-monster-beverage-why-m-a-in-energy-drinks-">energy drink deals</a>. Ghost belongs to Keurig Dr Pepper (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KDP#NASDAQ">KDP</a>) and Bang Energy is owned by Monster, and PepsiCo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>) purchased Rockstar Energy for $3.9 billion.</li>
</ul>
<ul>
<li>Valvoline (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VVV#NYSE">VVV</a>) <a href="https://www.businesswire.com/news/home/20250220946779/en/Greenbriar-Signs-Agreement-to-Sell-Breeze-Autocare-to-Valvoline">purchased</a> Breeze Autocare, an automotive maintenance services company, from Greenbriar Equity Group for $625 million. Breeze tapped Jefferies LLC and Piper Sandler &amp; Co. as financial advisors. Kirkland &amp; Ellis LLP handled legal matters. Morgan Stanley &amp; Co. LLC advised Lexington, Kentucky-based Valvoline on the purchase.</li>
</ul>
For last week&#8217;s edition of the <a href="https://www.benzinga.com/news/25/02/43749625/deal-dispatch-ny-giants-look-to-score-some-private-equity-plus-ma-volume-is-down">Deal Dispatch, click here</a>.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/real-estate/25/02/43886371/jason-statham-lists-beverly-hills-home-for-20-million-heres-a-look-at-the-british-action-heros-real-estate-portfolio">Action Hero Jason Statham Lists Beverly Hills Home For $20 Million</a></li>
</ul>
Image created using a photo from Shutterstock.

Asset Sales

CELH

DLTR

Deal Dispatch: Hooters Plans Restructuring, Prada In Talks To Acquire Versace

Chart Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GTLS#NYSE">GTLS</a>) has outperformed the market over the past 5 years by 9.96% on an annualized basis producing an average annual return of 23.88%. Currently, Chart Industries has a market capitalization of $7.79 billion. 
Buying $1000 In GTLS: If an investor had bought $1000 of GTLS stock 5 years ago, it would be worth $2,719.75 today based on a price of $181.87 for GTLS at the time of writing.
<h3>Chart Industries's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740176109_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GTLS

Here's How Much You Would Have Made Owning Chart Industries Stock In The Last 5 Years

Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) more than doubled its bonus plan for company executives after announcing layoffs for about 3,600 <a href="https://www.benzinga.com/25/02/43874069/meta-slashes-employee-stock-awards-by-10-as-zuckerberg-pours-up-to-65-billion-into-ai-race-against-openai-alphabet-and-amazon-report">employees just last month.&nbsp;</a>
The Details: According to an SEC <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1326801/000132680125000021/meta-20250213.htm">filing</a>, on Feb. 13, Meta approved a new bonus structure that raises the annual target bonus amount from 75% of each named executive officer's base salary to 200% of the base salary. 
The bonus structure excludes CEO Mark Zuckerberg, according to the filing. 
Read Next: <a href="https://www.benzinga.com/general/market-summary/25/02/43884153/us-services-drop-sharply-darkening-picture-of-high-prices-uncertainty-economist-says">US Services Drop Sharply: &#8216;Darkening Picture&#8217; Of High Prices, Uncertainty, Economist Says</a>
The move to increase bonuses for Meta's executives comes after the company announced in January that it would be cutting 5% of its workforce. That&#8217;s about 3,600 employees. 
Meta described the cuts as "performance terminations" aimed at improving efficiency.
&#8220;I&#8217;ve decided to raise the bar on performance management and move out low-performers faster,&#8221; Zuckerberg wrote in an internal memo published by Bloomberg.&nbsp;
Former Meta employees<a href="https://www.benzinga.com/25/02/43723246/meta-faces-backlash-as-laid-off-workers-say-they-were-unfairly-targeted-despite-strong-performance-records"> spoke out</a> on social media. They claim that some high performers, including those on parental and medical leave, were unfairly targeted in the layoffs.  
&#8220;Meta is now the cruelest tech company out there,&#8221; a former employee posted on Blind, an anonymous forum for tech industry insiders.&nbsp;
The backlash does seem to have affected Meta's stock, <a href="https://www.benzinga.com/25/02/43806703/mark-zuckerbergs-meta-platforms-dips-below-short-term-average-as-it-snaps-20-day-winning-run">which ran</a> on a 20-day winning streak just after the layoffs were announced. 
In the 20 trading sessions between Jan. 16 to Feb. 14, Meta's stock rose 20.22%, and the company added over $350 billion in market capitalization during this period.
Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Meta shares ended Friday's session down 1.62% at $683.55 amid a broad market selloff. 
Read Next:<a href="https://www.benzinga.com/25/02/43836832/trump-administration-orders-sweeping-pentagon-cuts-defense-sector-stocks-on-watch">&nbsp;</a>
<ul>
<li><a href="https://www.benzinga.com/25/02/43836832/trump-administration-orders-sweeping-pentagon-cuts-defense-sector-stocks-on-watch">Trump Administration Orders Sweeping Pentagon Cuts: Palantir, Lockheed Martin, General Dynamics Among Stocks On Watch</a></li>
</ul>
Image: Shutterstock

Large Cap

Social Media

Movers

General

Meta Follows Layoffs With Double Bonus Structure For Executives

In the last three months, 4 analysts have published ratings on Intra-Cellular Therapies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITCI#NASDAQ">ITCI</a>), offering a diverse range of perspectives from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $124.0, a high estimate of $132.00, and a low estimate of $100.00. This current average has increased by 14.29% from the previous average price target of $108.50. 
<img src="https://www.benzinga.com/files/images/story/2025/1740175266_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The analysis of recent analyst actions sheds light on the perception of Intra-Cellular Therapies by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Sumant Kulkarni</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Hold</td>
<td>$132.00</td>
<td>$119.00</td>
</tr>
<tr>
<td>Brian Abrahams</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$132.00</td>
<td>$108.00</td>
</tr>
<tr>
<td>David Amsellem</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$132.00</td>
<td>$107.00</td>
</tr>
<tr>
<td>Ami Fadia</td>
<td>Needham</td>
<td>Maintains</td>
<td>Hold</td>
<td>$100.00</td>
<td>$100.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Intra-Cellular Therapies. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Intra-Cellular Therapies compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Intra-Cellular Therapies's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Intra-Cellular Therapies's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ITCI/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Intra-Cellular Therapies analyst ratings.</a>
<h2>Get to Know Intra-Cellular Therapies Better</h2>
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.
<h3>Understanding the Numbers: Intra-Cellular Therapies's Finances</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Over the 3 months period, Intra-Cellular Therapies showcased positive performance, achieving a revenue growth rate of 39.23% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Health Care sector.
Net Margin: Intra-Cellular Therapies's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of -15.03%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -2.3%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -1.99%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: Intra-Cellular Therapies's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.02.
<h2>Analyst Ratings: What Are They?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

ITCI

Intra-Cellular Therapies Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

Earnings

Press Releases

Moleculin Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Moleculin Receives Institutional Review Board Approval for MIRACLE Phase 3 Pivotal Trial of Annamycin in Combination with Cytarabine for the Treatment of R/R Acute Myeloid Leukemia (AML)

Moleculin Accelerates Planned Unblinded Data Readout for MIRACLE Phase 3 R/R Acute Myeloid Leukemia (AML) Pivotal Trial to H2 2025

New Findings Show Moleculin's Annamycin Overcomes Resistance to Venetoclax in AML

Small Cap

Moleculin Announces Online Publication of Preclinical Data Demonstrating Significant Activity of Annamycin in Venetoclax Resistant AML Model

Moleculin Highlights Development Progress of Annamycin, Phase 2 Data Outperforms Billion-Dollar Assets in AML, Phase 3 Data Readouts in 2025 & 2026

Moleculin Participates in Virtual Investor "What This Means" Segment

Moleculin Receives First Country Approval in Europe to Begin Recruiting for the MIRACLE Phase 3 R/R Acute Myeloid Leukemia (AML) Pivotal Trial

Moleculin Receives Positive FDA Guidance for Acceleration of its Registration-Enabling MIRACLE Trial for R/R Acute Myeloid Leukemia (AML)

Offerings

Moleculin Announces Exercise of Warrants for $5.8 Million Gross Proceeds

MBRX

Allarity Therapeutics, Inc. - Common stock

Allarity Therapeutics

Alzamend Neuro

Aptevo Therapeutics

180 Life Sciences

Anitra

CERo Therapeutics Holdings, Inc. - Common Stock

CERo Therapeutics Hldgs

Cyclacel Pharmaceuticals, Inc. - Common Stock

Cyclacel Pharmaceuticals

Dermata Therapeutics, Inc. - Common Stock

Dermata Therapeutics

Galecto

GT Biopharma

Kazia Therapeutics Limited - American Depositary Shares

Kazia Therapeutics

Lipella Pharmaceuticals Inc. - Common Stock

Lipella Pharmaceuticals

Onconetix

Organovo Holdings

Psyence Biomedical Ltd. - Ordinary Shares

Psyence Biomedical

Polyrizon

Plus Therapeutics

TransCode Therapeutics, Inc. - Common Stock

TransCode Therapeutics

Sunshine Biopharma

SILO Pharma

Soligenix

Sonnet BioTherapeutics Holdings, Inc. - Common Stock

Sonnet BioTherapeutics

Syros Pharmaceuticals, Inc. - Common Stock

Comments

Moleculin Biotech

뉴스

에 대한 최신 뉴스 Moleculin Biotech (NASDAQ:MBRX) 주식

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌